Zhenying Wu

机构：Wuhan University, Zhongnan Hospital of Wuhan University

发表论文 18 篇 · 总被引 421 次 · h-index 12

代表论文

• PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study (2022 · Frontiers in Immunology · 被引 59)
• Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study (2022 · Hepatology International · 被引 48)
• PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma (2022 · Frontiers in Oncology · 被引 47)
• Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period (2023 · Frontiers in Immunology · 被引 42)
• Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study (2023 · Journal of Hepatocellular Carcinoma · 被引 42)
• External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis (2022 · Clinical and Experimental Medicine · 被引 42)